A Path to Protection Podcast 2: Purposeful Solutions to Power Up Influenza Vaccine Uptake

The CDC characterized the 2025-2026 influenza season as moderate overall, but the burden in the United States was substantial, with suboptimal seasonal influenza vaccine uptake among adults and children. It is important to communicate to patients that the clinical benefits of the influenza vaccine extend beyond prevention of disease and mortality, particularly for the most vulnerable populations. In anticipation of the upcoming influenza season, stream this podcast, featuring audio from a live webinar led by experts Paul G. Auwaerter, MD, MBA, and Ravi Jhaveri, MD, FIDSA, FPIDS, FAAP, to increase your competence in optimizing influenza vaccine uptake in pediatric and adult patients.

For more, and to download the accompanying slides, visit our program page.

Topics covered include:

Flu Vaccines for the 2026-2027 SeasonA Preview of the 2026-2027 Season From the Southern HemisphereStrategies for Influenza Vaccine SelectionIntegrating New Developments Into Practice

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Paul G. Auwaerter, MD, MBA
Sherrilyn and Ken Fisher Professor of Medicine
Divisions of Infectious Diseases and General Internal Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland

Ravi Jhaveri, MD, FIDSA, FPIDS, FAAP
Division Head
Pediatric Infectious Diseases
Virginia H. Rogers Professor in Infectious Diseases
Ann & Robert H. Lurie Children’s Hospital of Chicago
Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.